ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S — Credit Rating and Financial Key Figures

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S (CVR number: 32323502) is a company from GENTOFTE. The company recorded a gross profit of 5567 kEUR in 2025. The operating profit was 5565 kEUR, while net earnings were -5238 kEUR. The profitability of the company measured by Return on Assets (ROA) was -6.3 %, which can be considered poor and Return on Equity (ROE) was -45.6 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -80.7 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S's liquidity measured by quick ratio was 3.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.